Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 273 for

Edit search filters
  1. SURPASS: A Randomized, Double-Blind, Multicenter Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus (CMV) Disease in CMV Seropositive Kidney Transplant Recipients

    Rochester, MN

  2. A Study To Evaluate the Effectiveness, Safety, And Tolerability of a Clostridium Difficile Vaccine In Adults 50 Years of Age and Older

    Rochester, MN

  3. Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

    Scottsdale/Phoenix, AZ

  4. Study for the Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant Recipients

    Rochester, MN

  5. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2

    Rochester, MN

  6. A Study to Evaluate Rivaroxaban to Reduce Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients with Acute COVID-19 Infection

    Rochester, MN

  7. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects

    Rochester, MN

  8. A Study of Clofazimine for Treating Patients with Drug Resistant Non-Tuberculous Mycobacterial Infections

    Rochester, MN

  9. Analytic Treatment Interruption (ATI) to Assess HIV Cure

    Rochester, MN

  10. Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment

    Rochester, MN

.

Mayo Clinic Footer